Author: Amrita Banerjee; Dipannita Santra; Smarajit Maiti
Title: Energetics based epitope screening in SARS CoV-2 (COVID 19) spike glycoprotein by Immuno-informatic analysis aiming to a suitable vaccine development Document date: 2020_4_5
ID: iy4knx7j_21
Snippet: Antigenecity of predicted epitopes were determined using Vaxigen v2.0 protective antigen, tumour antigens and subunit vaccines prediction server [30] . Vaxigen v2.0 uses auto cross covariance (ACC) transformation of selected protein sequences based on unique amino acid properties. Each sequence was used to find out 100 known antigen and 100 non-antigens......
Document: Antigenecity of predicted epitopes were determined using Vaxigen v2.0 protective antigen, tumour antigens and subunit vaccines prediction server [30] . Vaxigen v2.0 uses auto cross covariance (ACC) transformation of selected protein sequences based on unique amino acid properties. Each sequence was used to find out 100 known antigen and 100 non-antigens.
Search related documents:
Co phrase search for related documents- amino acid and cross covariance: 1
- amino acid and non antigen: 1
- amino acid and predict epitope: 1, 2, 3, 4, 5
- amino acid and protective antigen: 1, 2, 3, 4, 5
- amino acid and protein sequence: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- amino acid and subunit vaccine: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21
- amino acid and tumour antigen: 1
- auto cross covariance and cross covariance: 1, 2, 3
- auto cross covariance and protein sequence: 1
- cross covariance and protein sequence: 1
- non antigen and protective antigen: 1, 2, 3
- non antigen and subunit vaccine: 1, 2
- predict epitope and protective antigen: 1
- predict epitope and protein sequence: 1, 2
- protective antigen and subunit vaccine: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- protein sequence and subunit vaccine: 1, 2, 3, 4, 5
Co phrase search for related documents, hyperlinks ordered by date